TRIDENT LIFELINE
Back to Cashflow Statement
|
TRIDENT LIFELINE Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-4.31 Cr | ₹-7.13 Cr | ₹14 Cr | ₹0.14 Cr |
What is the latest Net Cash Inflow / Outflow ratio of TRIDENT LIFELINE ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-4.31 Cr |
| Mar2024 | ₹-7.13 Cr |
| Mar2023 | ₹14 Cr |
| Mar2022 | ₹0.14 Cr |
How is Net Cash Inflow / Outflow of TRIDENT LIFELINE Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-4.31 Cr | Negative | |
| Mar2024 | ₹-7.13 Cr | Negative | |
| Mar2023 | ₹14 Cr | 9,474.65 | |
| Mar2022 | ₹0.14 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹286.6 Cr | -7.3% | -14.9% | -12.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,000.0 Cr | -0.4% | 5.3% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -4.3% | -6.3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 0.4% | 8.2% | 44.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 0.5% | 1.8% | 16.4% | Stock Analytics | |
| CIPLA | ₹106,150.0 Cr | -0.8% | -2.6% | -9.2% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -7.3% |
-14.9% |
-12.1% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses